Yes. However, in order for the refill reminders or other program communications to fall within the “refill reminder” exception to marketing, any financial remuneration received by the business associate from the pharmaceutical manufacturer (either directly or through the covered entity) must not exceed the fair market value of the business associate’s services. See paragraph (2)(i) of the definition of “marketing” at 45 CFR 164.501. Such limitations do not apply to what the covered entity itself may pay the business associate for such services when no financial remuneration is received from the pharmaceutical manufacturer or other third party whose product or service is being described.
